Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1973-3-2
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0485-1439
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
527-34
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4539473-Antibodies, Antinuclear,
pubmed-meshheading:4539473-Complement System Proteins,
pubmed-meshheading:4539473-DNA,
pubmed-meshheading:4539473-Humans,
pubmed-meshheading:4539473-Kidney,
pubmed-meshheading:4539473-Lupus Erythematosus, Systemic,
pubmed-meshheading:4539473-Nephritis,
pubmed-meshheading:4539473-Skin
|
pubmed:year |
1972
|
pubmed:articleTitle |
[Clinical studies on anti-nuclear factor in the patients with systemic lupus erythematosus concerning possible role on pathogenesis].
|
pubmed:publicationType |
Journal Article
|